Gen Z financial literacy program expands its scam prevention training
The Your Money Students program updated to better assist young Canadians spot scams TORONTO, Nov. 3, 2025 /CNW/ – To mark the start of Financial Literacy Month,... Read more.
CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B
SHANGHAI, Nov. 3, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies,... Read more.
NeuroSense to Host Investor Webinar on December 8, 2025
Business, regulatory and clinical updates will be provided CAMBRIDGE, Mass., Nov. 3, 2025 /PRNewswire/ — NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense”),... Read more.
Manulife Completes Acquisition of Comvest Credit Partners
TSX/NYSE/PSE: MFC SEHK: 945 TORONTO, Nov. 3, 2025 /PRNewswire/ – Manulife Financial Corporation (TSX: MFC), through its more than US$900 billion Global... Read more.
SAS again places No. 2 overall in Chartis RiskTech100
In world’s most prestigious risk management technology rankings, SAS tops 7 solution awards categories CARY, N.C., Nov. 3, 2025 /PRNewswire/ — SAS has... Read more.
Strategic Partnerships Fuel JA Canada’s Renewal of Investment Strategies Program
With support of CIRO, WealthSimple Foundation, and a consortium of partners, JA in Canada will equip over 25,000 students annually with responsible investment education.... Read more.
Matson Partners with WhaleSpotter to Commercialize Breakthrough Whale Detection Technology
First container shipping company to adopt Woods Hole Oceanographic Institution system HONOLULU, Nov. 3, 2025 /PRNewswire/ — Matson, Inc. (“Matson”)... Read more.
Infinite Electronics and RS Group Expand Partnership to Deliver L-com Connectivity Solutions to European and APAC Markets
Expanded distribution underscores Infinite’s global growth strategy, giving European and APAC customers broader access to L-com’s trusted connectivity... Read more.
Enliven Therapeutics Announces Clinical Data in CML Patients with Atypical Fusion Transcripts at ASH 2025 Annual Meeting
ELVN-001 demonstrates encouraging anti-CML activity in heavily pretreated patients with atypical fusion transcripts Growing unmet need for patients with atypical... Read more.
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
Oral presentation to feature updated data from the ongoing Phase 1b study evaluating R289, Rigel’s dual IRAK1/4 inhibitor, in patients with relapsed or refractory... Read more.